Suppr超能文献

维拉帕米与锂盐用于躁狂症患者的维持治疗

Verapamil and lithium in maintenance therapy of manic patients.

作者信息

Giannini A J, Taraszewski R, Loiselle R H

机构信息

Ohio State University, Youngstown.

出版信息

J Clin Pharmacol. 1987 Dec;27(12):980-2. doi: 10.1002/j.1552-4604.1987.tb05600.x.

Abstract

A year-long double-blind cross-over study was used to compare the long-term therapeutic effects of lithium versus verapamil in a group of 20 manic volunteers. Subjects received each medication for six months. Before cross-over, verapamil patients showed a significant improvement after 60 days, lithium-treated patients after 180 days. After cross-over, verapamil-treated subjects showed improvement at day 240. Lithium-treated patients showed no improvement after cross-over. The data indicate that verapamil may be effective as an agent in the maintenance treatment of manic patients.

摘要

一项为期一年的双盲交叉研究被用于比较锂盐与维拉帕米对一组20名躁狂志愿者的长期治疗效果。受试者每种药物服用六个月。在交叉用药前,维拉帕米组患者在60天后有显著改善,锂盐治疗组患者在180天后有改善。交叉用药后,维拉帕米治疗组受试者在240天时出现改善。锂盐治疗组患者交叉用药后没有改善。数据表明维拉帕米可能作为一种药物在躁狂患者的维持治疗中有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验